Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Vertex Pharmaceuticals Inc
VRTX
Healthcare
Biotechnology
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age...
and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The company also develops CASGEVY for the treatment of sickle cell disease and transfusion-dependent beta thalassemia; JOURNAVX for the treatment of acute pain in adults; VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1/2 clinical trial; inaxaplin for the treatment of APOL1-mediated kidney disease which is in single Phase 2; VX-880 and VX-264, treatment for Type 1 Diabetes; VX-670 for the treatment of ...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:VRTX)
New Post
View:
Posts & Comments
Threaded Posts
(20)
•••
gourt12
X
Post by
gourt12
on Dec 19, 2024 1:12pm
Keep steady
Bought in today. Do not overreact to the news. Firstly sciatic studies are well known for high placebo responder groups. The current first line medication pregabalin also gives around a 20% reduction
...more
(33)
•••
SmartBull65
X
Post by
SmartBull65
on Nov 30, 2024 11:19am
VRTX: Strong Growth, But Watch the Pipeline
VRTX is on fire right now with their CF portfolio—Trikafta is still bringing in the revenue. But the real play could be in their gene-editing work with CRISPR. If their sickle cell treatment pans out,
...more
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 4:13am
Vertex Pharmaceuticals (NASDAQ:VRTX) – A Diversified P
https://beyondspx.com/2024/08/02/vertex-pharmaceuticals-nasdaqvrtx-a-diversified-powerhouse-delivering-transformative-medicines/
(1)
•••
TechTitan
X
Post by
TechTitan
on Jul 15, 2023 11:20am
Very Bullish
Glad I bought some in March! who will lead in treating CF? VRTX or KRYS? Both show huge potential
(161)
•••
Bullknit101
X
Post by
Bullknit101
on Sep 26, 2021 3:05pm
Benefits of Rare Cannabinoids
Big Pharma is about to get into research of a new class of drugs, rare Cannabinoids, a $10B market by 2025. Vertex would benefit from this area: https://youtu.be/i7nlfnWlpPs
(4)
•••
Mil_Man54
X
Post by
Mil_Man54
on Dec 26, 2020 8:26am
Bonvoyage12....Lying Pumper
Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on multiple boards
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Sego completes four drill holes at South Gold Zone, Cuba Zone deep hole underway
DiagnosTear Announces Clinical Study to Advance Analytical Validation & FDA Submission Pathway of TeaRx(TM)
A Company Focused on Developing Functional Healthier “Better For You” Foods
Building Momentum in One of the World's Most Prospective Copper Regions
Sorrento Resources Provides Update on Exploration on Rodgers Cove Project, Newfoundland
A tungsten producer and developer in Portugal, South Korea & Spain on track to become a top supplier